Yulang Jiang
Biographic Data
| ID | 7300461 |
|---|---|
| NAME | Yulang Jiang |
| GIVEN NAMES | Yulang |
| FAMILY NAME | Jiang |
| SIGNATURE | JIANG Y |
| AFFILIATIONS | Shanghai University of Traditional Chinese Medicine |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Alizarin as an NLRP3 Inflammasome Blocker Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease
Exploring the mechanisms of WeifuChun in colorectal cancer: Network pharmacology-based identification and experimental validation of key signaling pathways
Weifuchun inhibits gastric cancer metastasis by inhibiting angiogenesis mediated by the miR-139-5p/CXCR4 axis
Modified Banxiaxiexin decoction benefitted chemotherapy in treating gastric cancer by regulating multiple targets and pathways
No prominent works on this page.
Modified Banxiaxiexin decoction benefitted chemotherapy in treating gastric cancer by regulating multiple targets and pathways
Alizarin as an NLRP3 Inflammasome Blocker Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease
Exploring the mechanisms of WeifuChun in colorectal cancer: Network pharmacology-based identification and experimental validation of key signaling pathways
Weifuchun inhibits gastric cancer metastasis by inhibiting angiogenesis mediated by the miR-139-5p/CXCR4 axis
Cancer (3 works) · Andrographolide Research and Applications (2 works) · Biology (2 works) · Cancer Mechanisms and Therapy (2 works) · Chemotherapy (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pharmacology (2 works) · Alizarin (1 works) · Angiogenesis (1 works)